Imperagen
ultra-fast enzyme engineering platform
Imperagen has raised €9.9M across 2 funding rounds from 3 investors, most recently a Seed round in May 2026. Based in Manchester, UK; active in Healthtech. Data as of 4 Nov 2026.
Manchester, UKimperagen.com ↗
Total raised
€9.9M
€9,925,860
Funding rounds
2
Investors
3
distinct backers
Active since
2022-08
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDImperagen — funding by year — interactive chart.
Data table
| Imperagen — funding by year | |
|---|---|
| 2022 | €4.1M |
| 2026 | €5.8M |
Signals
High confidenceRaise-next likelihood41
base rate 44% for Seed
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-21 | Seed | €5.8M | IQ Capital,Northern Gritstone,PXN Ventures | View deal → |
| 2022-08-09 | Seed | €4.1M | IQ Capital,Northern Gritstone | View deal → |
Investors
3Related news
- Life sciences spin-out Imperagen secures £3.5m seed investmentbusinesscloud.co.uk · 2022-08
- tech.eu
Similar companies
same sector, similar size- Circle Health€9.0MUK · Healthtech
- Helical€8.5MUK · Healthtech
- Scripta Therapeutics€10MUK · Healthtech
- Neuranics€9.4MUK · Healthtech
- XRlabs€7.5MUK · Healthtech
- Vivid Dx€13MUK · Healthtech
Global coverage: FundingData